Coronavirus (COVID-19) updates for UC San Diego Health patients and visitors. Learn More.
About Lisa Madlensky, PhD, CGC
Lisa Madlensky, PhD, is a board-certified genetic counselor who provides cancer risk assessment and genetic counseling for patients and their families. She helps people investigate their family health history, navigate the genetic testing process, and understand and adapt to the medical or psychological implications of genetic diseases.
As director of the Family Cancer Genetics Program at Moores Cancer Center at UC San Diego Health, Dr. Madlensky helps ensure that patients and families with an increased risk of cancer receive outstanding care, with a focus on cancer prevention and early detection.
In addition to her clinical activities, Dr. Madlensky is a researcher at Moores Cancer Center. Her work centers on cancer prevention in those at increased risk of disease because of their family history or genetic predisposition. Her research themes include clinical genetic testing and follow-up for families with Lynch Syndrome and BRCA1/2 mutations; the public health implications of cancer genetic testing; quality of life in those at increased risk of cancer; the integration of cancer risk assessment into family practice; and family-level cancer prevention.
Dr. Madlensky earned her doctoral degree from the University of Toronto Institute of Health Policy, Management and Evaluation. She obtained a Master of Science in genetic counseling from McGill University in Montreal Canada.
UC San Diego Health Links
For more information, see Genetic Counseling.
- University of Toronto, Ontario, Canada
Date Joined Staff
- American Board of Genetic Counseling
Conditions and Treatments
- Breast Cancer
- Endometrial Cancer
- Gastric Cancer
- Pancreatic Cancer
- Gastrointestinal Malignancies Including Colon
- Ovarian Cancer
- Acute Lymphoblastic Leukemia
- Cancer Risk Assessment
- Personalized Medicine
Meet Dr. Lisa Madlensky, UC San Diego CIRM Alpha Stem Cell ClinicMore videos
- Here we talk to Richard Gallo, MD, PhD, a dermatologist and researcher whose team recently tested a “microbiome transplant” cream on a small group of eczema patients. People with eczema tend to have more Staphylococcus aureus bacteria on their skin than those who don’t, which can exacerbate the itchiness and inflammation. Unlike traditional antibiotics, which wipe out both harmful and beneficial bacteria indiscriminately, Gallo’s approach uses good bacteria to specifically fight off the bad.